Disease | macular degeneration |
Symptom | C0339546|retinal pigment epithelial detachment |
Sentences | 4 |
PubMedID- 23819839 | Purpose: the aim of the study was to identify predictive factors for detection of impending retinal pigment epithelium (rpe) tears in patients under anti-vegf therapy for treatment of retinal pigment epithelial detachment (ped) due to exudative age-related macular degeneration (amd) using near-infrared reflectance imaging (nir), spectral-domain optical coherence tomography (sd-oct) and fluorescein angiography (fla). |
PubMedID- 23558214 | Purpose: the aim of this study is to report the short-term efficacy of aflibercept in the treatment of neovascular age-related macular degeneration (amd) with associated retinal pigment epithelial detachment (ped) which is refractory or develops tachyphylaxis to bevacizumab and ranibizumab. |
PubMedID- 25277305 | Summary statement: intravitreal high dose (2 mg) ranibizumab may lead to quicker resolution of choroidal neovascularization (cnv) and associated retinal pigment epithelial detachment in eyes with exudative age-related macular degeneration, although it may possibly correlate with rpe tears in certain cases. |
PubMedID- 22207117 | Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration. |
Page: 1